| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 41 | 2022 | 338 | 9.860 |
Why?
|
| Breast Feeding | 25 | 2022 | 134 | 7.030 |
Why?
|
| Pregnancy | 90 | 2024 | 1484 | 6.240 |
Why?
|
| Lactation | 19 | 2022 | 50 | 5.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2022 | 742 | 4.630 |
Why?
|
| Premature Birth | 10 | 2020 | 135 | 3.930 |
Why?
|
| Obesity | 24 | 2023 | 839 | 2.940 |
Why?
|
| Female | 116 | 2024 | 12838 | 2.810 |
Why?
|
| Postpartum Period | 20 | 2024 | 93 | 2.490 |
Why?
|
| Risk Factors | 56 | 2024 | 3394 | 2.430 |
Why?
|
| Adult | 86 | 2024 | 7696 | 2.430 |
Why?
|
| Coronary Artery Disease | 8 | 2021 | 132 | 2.410 |
Why?
|
| Humans | 119 | 2024 | 18058 | 2.380 |
Why?
|
| Longitudinal Studies | 32 | 2024 | 705 | 2.350 |
Why?
|
| Parity | 18 | 2021 | 75 | 2.330 |
Why?
|
| Weight Gain | 17 | 2021 | 180 | 2.250 |
Why?
|
| Prospective Studies | 34 | 2021 | 1294 | 2.220 |
Why?
|
| European Continental Ancestry Group | 19 | 2020 | 559 | 2.180 |
Why?
|
| Young Adult | 40 | 2024 | 2479 | 2.100 |
Why?
|
| Metabolic Syndrome | 6 | 2016 | 80 | 1.780 |
Why?
|
| Lipids | 9 | 2021 | 77 | 1.750 |
Why?
|
| Pregnancy Complications | 9 | 2021 | 193 | 1.750 |
Why?
|
| Cardiovascular Diseases | 15 | 2024 | 613 | 1.730 |
Why?
|
| Blood Glucose | 17 | 2021 | 344 | 1.630 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2020 | 56 | 1.560 |
Why?
|
| Pregnancy Complications, Cardiovascular | 5 | 2021 | 28 | 1.510 |
Why?
|
| Infant, Newborn | 19 | 2021 | 852 | 1.500 |
Why?
|
| Body Weight | 14 | 2018 | 216 | 1.440 |
Why?
|
| Cohort Studies | 35 | 2024 | 2631 | 1.410 |
Why?
|
| Adolescent | 33 | 2023 | 3714 | 1.400 |
Why?
|
| African Continental Ancestry Group | 9 | 2019 | 165 | 1.320 |
Why?
|
| Cardiorespiratory Fitness | 2 | 2018 | 9 | 1.270 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2023 | 41 | 1.240 |
Why?
|
| Infant, Premature | 3 | 2018 | 60 | 1.170 |
Why?
|
| Glucose Intolerance | 3 | 2018 | 45 | 1.160 |
Why?
|
| Insulin | 9 | 2018 | 208 | 1.110 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2015 | 7 | 1.100 |
Why?
|
| Body Mass Index | 28 | 2024 | 961 | 1.090 |
Why?
|
| Pre-Eclampsia | 2 | 2023 | 38 | 1.090 |
Why?
|
| Pregnancy Outcome | 7 | 2021 | 158 | 1.060 |
Why?
|
| African Americans | 10 | 2020 | 485 | 1.060 |
Why?
|
| Time Factors | 18 | 2020 | 1114 | 0.990 |
Why?
|
| Blood Pressure | 6 | 2023 | 280 | 0.960 |
Why?
|
| Overweight | 7 | 2021 | 272 | 0.960 |
Why?
|
| Exercise | 3 | 2018 | 478 | 0.940 |
Why?
|
| Gestational Age | 5 | 2020 | 119 | 0.930 |
Why?
|
| Coronary Vessels | 3 | 2024 | 15 | 0.920 |
Why?
|
| Prenatal Care | 5 | 2024 | 136 | 0.910 |
Why?
|
| Coronary Disease | 5 | 2015 | 182 | 0.890 |
Why?
|
| Follow-Up Studies | 16 | 2020 | 1255 | 0.860 |
Why?
|
| United States | 20 | 2021 | 4119 | 0.860 |
Why?
|
| Mothers | 3 | 2018 | 110 | 0.840 |
Why?
|
| Incidence | 15 | 2021 | 1297 | 0.810 |
Why?
|
| Hypertension | 4 | 2023 | 489 | 0.780 |
Why?
|
| Adipose Tissue | 3 | 2015 | 59 | 0.780 |
Why?
|
| Middle Aged | 34 | 2021 | 8073 | 0.750 |
Why?
|
| Diabetes Mellitus | 5 | 2019 | 526 | 0.750 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 18 | 0.730 |
Why?
|
| Carotenoids | 1 | 2020 | 30 | 0.720 |
Why?
|
| Antioxidants | 1 | 2020 | 39 | 0.720 |
Why?
|
| Glucose Tolerance Test | 6 | 2016 | 106 | 0.720 |
Why?
|
| Infant | 10 | 2018 | 1212 | 0.700 |
Why?
|
| Waist Circumference | 7 | 2020 | 37 | 0.670 |
Why?
|
| Insulin Resistance | 5 | 2017 | 129 | 0.670 |
Why?
|
| Preconception Care | 4 | 2019 | 45 | 0.660 |
Why?
|
| Kidney | 1 | 2019 | 53 | 0.660 |
Why?
|
| Vascular Calcification | 1 | 2018 | 9 | 0.640 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 156 | 0.640 |
Why?
|
| Hemodynamics | 1 | 2018 | 7 | 0.640 |
Why?
|
| Adiposity | 3 | 2015 | 66 | 0.610 |
Why?
|
| Maternal-Child Health Services | 1 | 2017 | 1 | 0.610 |
Why?
|
| California | 13 | 2024 | 2327 | 0.600 |
Why?
|
| Diabetes Complications | 4 | 2019 | 120 | 0.600 |
Why?
|
| Multivariate Analysis | 7 | 2019 | 595 | 0.580 |
Why?
|
| Hospitals | 1 | 2017 | 79 | 0.570 |
Why?
|
| Infant Formula | 2 | 2017 | 11 | 0.560 |
Why?
|
| Obesity, Abdominal | 2 | 2015 | 10 | 0.560 |
Why?
|
| Population Surveillance | 1 | 2018 | 270 | 0.560 |
Why?
|
| Linear Models | 8 | 2020 | 240 | 0.540 |
Why?
|
| Health Status | 1 | 2018 | 331 | 0.530 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 9 | 0.520 |
Why?
|
| Dyslipidemias | 2 | 2020 | 63 | 0.520 |
Why?
|
| Cardiomyopathies | 2 | 2013 | 8 | 0.520 |
Why?
|
| Women's Health | 3 | 2021 | 208 | 0.510 |
Why?
|
| Child Development | 1 | 2015 | 49 | 0.510 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 205 | 0.500 |
Why?
|
| Adiponectin | 2 | 2014 | 22 | 0.500 |
Why?
|
| Leptin | 2 | 2014 | 30 | 0.500 |
Why?
|
| Pregnancy in Diabetics | 4 | 2008 | 21 | 0.490 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 11 | 0.480 |
Why?
|
| Disease Progression | 6 | 2020 | 255 | 0.460 |
Why?
|
| Prediabetic State | 1 | 2014 | 50 | 0.460 |
Why?
|
| Risk Assessment | 9 | 2020 | 1137 | 0.450 |
Why?
|
| Body Constitution | 2 | 2004 | 36 | 0.440 |
Why?
|
| Inflammation | 1 | 2013 | 61 | 0.430 |
Why?
|
| Cholesterol | 2 | 2010 | 112 | 0.430 |
Why?
|
| Odds Ratio | 9 | 2017 | 692 | 0.430 |
Why?
|
| Body Height | 3 | 2009 | 59 | 0.420 |
Why?
|
| Anthropometry | 5 | 2015 | 63 | 0.410 |
Why?
|
| Puerperal Disorders | 1 | 2011 | 9 | 0.400 |
Why?
|
| Sleep | 3 | 2010 | 56 | 0.400 |
Why?
|
| Research Design | 5 | 2019 | 393 | 0.400 |
Why?
|
| Feeding Behavior | 2 | 2017 | 165 | 0.400 |
Why?
|
| Weight Loss | 3 | 2015 | 296 | 0.390 |
Why?
|
| Pregnancy in Adolescence | 2 | 2009 | 9 | 0.390 |
Why?
|
| Male | 19 | 2023 | 10173 | 0.380 |
Why?
|
| Prevalence | 9 | 2017 | 892 | 0.380 |
Why?
|
| Surveys and Questionnaires | 9 | 2016 | 1346 | 0.360 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 14 | 0.350 |
Why?
|
| Parturition | 1 | 2009 | 10 | 0.350 |
Why?
|
| Logistic Models | 7 | 2021 | 953 | 0.350 |
Why?
|
| Maternal Welfare | 1 | 2009 | 15 | 0.340 |
Why?
|
| Gravidity | 3 | 2017 | 8 | 0.340 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 248 | 0.340 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 1023 | 0.330 |
Why?
|
| Aging | 3 | 2021 | 159 | 0.320 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 13 | 0.320 |
Why?
|
| Body Fat Distribution | 1 | 2008 | 5 | 0.320 |
Why?
|
| Retrospective Studies | 6 | 2023 | 2498 | 0.320 |
Why?
|
| Multicenter Studies as Topic | 3 | 2018 | 81 | 0.310 |
Why?
|
| Analysis of Variance | 4 | 2018 | 162 | 0.310 |
Why?
|
| Nutritional Requirements | 2 | 2004 | 6 | 0.310 |
Why?
|
| Maternal Exposure | 2 | 2019 | 54 | 0.310 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 35 | 0.300 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 144 | 0.300 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 667 | 0.300 |
Why?
|
| Biomarkers | 4 | 2021 | 306 | 0.290 |
Why?
|
| Self Report | 2 | 2019 | 252 | 0.290 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2017 | 7 | 0.290 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2006 | 8 | 0.290 |
Why?
|
| Body Composition | 3 | 2013 | 80 | 0.270 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 10 | 0.270 |
Why?
|
| Blood Pressure Determination | 2 | 2023 | 56 | 0.270 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 80 | 0.260 |
Why?
|
| Child | 7 | 2024 | 2519 | 0.260 |
Why?
|
| Life Style | 5 | 2015 | 329 | 0.260 |
Why?
|
| Registries | 2 | 2006 | 486 | 0.250 |
Why?
|
| Glycated Hemoglobin A | 4 | 2015 | 231 | 0.250 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2022 | 5 | 0.250 |
Why?
|
| Animals | 2 | 2022 | 250 | 0.250 |
Why?
|
| Infant, Low Birth Weight | 2 | 2020 | 35 | 0.240 |
Why?
|
| Metabolomics | 1 | 2023 | 8 | 0.230 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2003 | 15 | 0.230 |
Why?
|
| Age Factors | 5 | 2014 | 945 | 0.230 |
Why?
|
| Heart Failure | 3 | 2021 | 391 | 0.230 |
Why?
|
| Child Abuse | 1 | 2024 | 43 | 0.220 |
Why?
|
| Dietary Proteins | 1 | 2022 | 19 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 205 | 0.220 |
Why?
|
| Health Promotion | 2 | 2017 | 295 | 0.220 |
Why?
|
| Risk | 4 | 2017 | 552 | 0.210 |
Why?
|
| Birth Order | 2 | 2024 | 5 | 0.210 |
Why?
|
| Atherosclerosis | 2 | 2020 | 51 | 0.200 |
Why?
|
| Smoking | 1 | 2004 | 465 | 0.200 |
Why?
|
| Health Status Disparities | 1 | 2023 | 154 | 0.200 |
Why?
|
| Thinness | 1 | 2021 | 29 | 0.190 |
Why?
|
| Weaning | 2 | 2013 | 6 | 0.190 |
Why?
|
| DNA Methylation | 1 | 2021 | 41 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 249 | 0.190 |
Why?
|
| Prognosis | 4 | 2020 | 619 | 0.190 |
Why?
|
| Amino Acids | 1 | 2020 | 3 | 0.190 |
Why?
|
| Television | 2 | 2018 | 24 | 0.180 |
Why?
|
| Hot Flashes | 1 | 2020 | 39 | 0.180 |
Why?
|
| Ethnic Groups | 4 | 2015 | 504 | 0.180 |
Why?
|
| Paternal Exposure | 1 | 2019 | 5 | 0.180 |
Why?
|
| Menopause | 1 | 2020 | 72 | 0.180 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 160 | 0.180 |
Why?
|
| Health Surveys | 2 | 2017 | 266 | 0.170 |
Why?
|
| Creatine | 1 | 2019 | 4 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2019 | 89 | 0.170 |
Why?
|
| Dietary Supplements | 3 | 2011 | 91 | 0.160 |
Why?
|
| Coronary Angiography | 1 | 2018 | 22 | 0.160 |
Why?
|
| Maternal Health | 1 | 2018 | 4 | 0.160 |
Why?
|
| Carnitine | 1 | 2018 | 3 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 407 | 0.160 |
Why?
|
| Poisson Distribution | 1 | 2018 | 92 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 19 | 0.160 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2017 | 19 | 0.150 |
Why?
|
| Telomere | 1 | 2017 | 19 | 0.150 |
Why?
|
| Aged | 12 | 2021 | 6258 | 0.150 |
Why?
|
| Skinfold Thickness | 2 | 2015 | 18 | 0.150 |
Why?
|
| Intention | 1 | 2017 | 28 | 0.150 |
Why?
|
| Regression Analysis | 1 | 2018 | 319 | 0.150 |
Why?
|
| Vitamins | 2 | 2011 | 66 | 0.150 |
Why?
|
| Primary Prevention | 1 | 2017 | 77 | 0.150 |
Why?
|
| Testosterone | 1 | 2017 | 22 | 0.150 |
Why?
|
| Health Behavior | 2 | 2013 | 379 | 0.150 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.150 |
Why?
|
| Educational Status | 2 | 2009 | 205 | 0.150 |
Why?
|
| Reproduction | 1 | 2016 | 12 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 36 | 0.140 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 29 | 0.140 |
Why?
|
| Sex Factors | 2 | 2020 | 634 | 0.140 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2014 | 23 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2016 | 17 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 15 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 21 | 0.130 |
Why?
|
| Interleukin-6 | 2 | 2013 | 25 | 0.130 |
Why?
|
| Birth Intervals | 1 | 2015 | 10 | 0.130 |
Why?
|
| Marriage | 1 | 2015 | 7 | 0.130 |
Why?
|
| Neoplasms | 1 | 2020 | 464 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 57 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 55 | 0.130 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 745 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 57 | 0.120 |
Why?
|
| Dementia | 2 | 2008 | 103 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 12 | 0.120 |
Why?
|
| Lipoproteins | 1 | 2014 | 14 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2015 | 152 | 0.120 |
Why?
|
| Fasting | 1 | 2013 | 47 | 0.120 |
Why?
|
| Birth Rate | 1 | 2013 | 6 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2015 | 248 | 0.110 |
Why?
|
| Alcohol Drinking | 2 | 2006 | 375 | 0.110 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 75 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 155 | 0.110 |
Why?
|
| Absorptiometry, Photon | 2 | 2012 | 59 | 0.110 |
Why?
|
| Parents | 1 | 2015 | 308 | 0.100 |
Why?
|
| Infant Food | 1 | 2011 | 8 | 0.100 |
Why?
|
| Hispanic Americans | 3 | 2012 | 431 | 0.100 |
Why?
|
| Bottle Feeding | 1 | 2011 | 8 | 0.100 |
Why?
|
| Contraception | 1 | 2011 | 25 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2018 | 1164 | 0.100 |
Why?
|
| Phenotype | 2 | 2016 | 145 | 0.100 |
Why?
|
| Hypoglycemic Agents | 4 | 2017 | 289 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2011 | 34 | 0.100 |
Why?
|
| Adipokines | 1 | 2011 | 5 | 0.100 |
Why?
|
| Massachusetts | 2 | 2008 | 100 | 0.100 |
Why?
|
| Postmenopause | 2 | 2021 | 266 | 0.090 |
Why?
|
| Triglycerides | 2 | 2024 | 86 | 0.090 |
Why?
|
| Sleep Deprivation | 1 | 2010 | 4 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2010 | 4 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 18 | 0.090 |
Why?
|
| Probability | 1 | 2009 | 86 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 5 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 145 | 0.080 |
Why?
|
| Survivors | 2 | 2011 | 157 | 0.080 |
Why?
|
| Asian Americans | 2 | 2017 | 184 | 0.080 |
Why?
|
| Maternal Age | 3 | 2017 | 79 | 0.080 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2008 | 4 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2008 | 11 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 318 | 0.080 |
Why?
|
| Leisure Activities | 1 | 2008 | 33 | 0.080 |
Why?
|
| Patient Care Planning | 1 | 2008 | 51 | 0.080 |
Why?
|
| Continental Population Groups | 1 | 2009 | 317 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 5 | 0.070 |
Why?
|
| Homeostasis | 1 | 2007 | 11 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 407 | 0.070 |
Why?
|
| Diet | 4 | 2014 | 359 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2007 | 47 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 350 | 0.070 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2008 | 44 | 0.070 |
Why?
|
| Dietetics | 1 | 2006 | 1 | 0.070 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 3 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 1956 | 0.070 |
Why?
|
| Twins, Dizygotic | 1 | 2006 | 8 | 0.070 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 12 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 43 | 0.070 |
Why?
|
| Ethanol | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 124 | 0.070 |
Why?
|
| Patient Selection | 1 | 2007 | 194 | 0.070 |
Why?
|
| Disclosure | 1 | 2006 | 19 | 0.070 |
Why?
|
| Environment | 2 | 2016 | 52 | 0.070 |
Why?
|
| Heart Rate | 2 | 2019 | 38 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1309 | 0.070 |
Why?
|
| Motor Activity | 3 | 2014 | 208 | 0.060 |
Why?
|
| Managed Care Programs | 2 | 2017 | 356 | 0.060 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 10 | 0.060 |
Why?
|
| Behavior | 1 | 2004 | 18 | 0.060 |
Why?
|
| Prejudice | 1 | 2004 | 24 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 324 | 0.060 |
Why?
|
| Longevity | 1 | 2024 | 13 | 0.060 |
Why?
|
| Glucose | 1 | 2024 | 30 | 0.060 |
Why?
|
| Workflow | 1 | 2023 | 11 | 0.060 |
Why?
|
| Comorbidity | 3 | 2015 | 618 | 0.060 |
Why?
|
| Computational Biology | 1 | 2023 | 28 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2003 | 5 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 17 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2002 | 9 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2002 | 5 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2002 | 30 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2002 | 42 | 0.050 |
Why?
|
| Breast | 1 | 2022 | 85 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2023 | 330 | 0.050 |
Why?
|
| Risk Reduction Behavior | 2 | 2015 | 114 | 0.050 |
Why?
|
| Live Birth | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2015 | 97 | 0.050 |
Why?
|
| Vitamin D | 1 | 2002 | 78 | 0.050 |
Why?
|
| Denmark | 1 | 2021 | 19 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 25 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 82 | 0.050 |
Why?
|
| United Kingdom | 1 | 2020 | 30 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2020 | 2 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 5 | 0.050 |
Why?
|
| Menarche | 1 | 2000 | 30 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 17 | 0.050 |
Why?
|
| Vasomotor System | 1 | 2020 | 5 | 0.050 |
Why?
|
| Sweating | 1 | 2020 | 9 | 0.050 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2000 | 92 | 0.050 |
Why?
|
| Infertility | 1 | 2019 | 3 | 0.040 |
Why?
|
| Infant Health | 1 | 2019 | 3 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2019 | 12 | 0.040 |
Why?
|
| Child Health | 1 | 2019 | 30 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 1428 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 121 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 186 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 181 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 1 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 12 | 0.040 |
Why?
|
| Mice | 1 | 2018 | 66 | 0.040 |
Why?
|
| Family Health | 1 | 2017 | 47 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2017 | 6 | 0.040 |
Why?
|
| Multidetector Computed Tomography | 1 | 2017 | 1 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 7 | 0.040 |
Why?
|
| Premenopause | 1 | 2017 | 27 | 0.040 |
Why?
|
| Fertility | 1 | 2016 | 10 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.040 |
Why?
|
| Energy Intake | 2 | 2013 | 100 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 33 | 0.030 |
Why?
|
| Echocardiography | 1 | 2016 | 30 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 15 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2015 | 53 | 0.030 |
Why?
|
| Food Supply | 1 | 2015 | 35 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2014 | 22 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 40 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 25 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 175 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 1992 | 27 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2006 | 1259 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 215 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2017 | 734 | 0.030 |
Why?
|
| Puberty | 1 | 2012 | 58 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 103 | 0.030 |
Why?
|
| Peptide YY | 1 | 2011 | 5 | 0.020 |
Why?
|
| Ghrelin | 1 | 2011 | 15 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 225 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 86 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2010 | 26 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 330 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 39 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2008 | 15 | 0.020 |
Why?
|
| Causality | 1 | 2008 | 43 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 57 | 0.020 |
Why?
|
| Social Class | 1 | 2008 | 125 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 22 | 0.020 |
Why?
|
| Liver | 1 | 2006 | 33 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 129 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2006 | 249 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 257 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2005 | 59 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2006 | 160 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2005 | 90 | 0.020 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2006 | 248 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 454 | 0.020 |
Why?
|
| Calcium | 1 | 2002 | 34 | 0.010 |
Why?
|
| Bone Density | 1 | 2002 | 98 | 0.010 |
Why?
|
| Quality of Life | 1 | 2005 | 509 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 512 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 303 | 0.010 |
Why?
|
| Diet, Diabetic | 1 | 1992 | 9 | 0.010 |
Why?
|
| Eating | 1 | 1992 | 37 | 0.010 |
Why?
|